Cantor Fitzgerald Maintains Overweight on Korro Bio, Raises Price Target to $22
Cantor Fitzgerald analyst Steve Seedhouse maintains Korro Bio (NASDAQ:KRRO) with a Overweight and raises the price target from $21 to $22.
Login to comment